Anterior nucleus of the thalamus deep brain stimulation vs temporal lobe responsive neurostimulation for temporal lobe epilepsy.
Jimmy C YangKatie L BullingerAdam S DickeyIoannis KarakisAbdulrahman AlwakiBrian T CabanissDaniel WinkelAndres Rodriguez-RuizJon T WillieRobert E GrossPublished in: Epilepsia (2022)
We demonstrate in our single-center experience that patients with drug-resistant TLE benefit similarly from either ANT-DBS or TL-RNS. Selection of either ANT-DBS or TL-RNS may, therefore, depend more heavily on patient and provider preference, as each has unique capabilities and configurations. Future studies will consider subgroup analyses to determine if specific patients have greater seizure frequency reduction from one form of neuromodulation strategy over another.
Keyphrases
- deep brain stimulation
- drug resistant
- parkinson disease
- temporal lobe epilepsy
- obsessive compulsive disorder
- multidrug resistant
- end stage renal disease
- acinetobacter baumannii
- chronic kidney disease
- newly diagnosed
- ejection fraction
- primary care
- case report
- randomized controlled trial
- cystic fibrosis
- double blind